Moses Shieh, DO
Surgery · Fort Myers, FLNPI 1457367955
Payments from drug & device makers
Across 230 payments — averaging $329.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$38K
- Intuitive Surgical$26K
- Medtronic$6K
- Acell, Inc.$4K
- TELA Bio, Inc.$203
- KCI USA, Inc.$194
- plus $2K from 27 others
Across 1 payment — averaging $12,700 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Integra Lifesciences Corporation$13K
What the payments were for
- Consulting fees$20,16731%
- Speaking & faculty fees$8,24813%
- Travel & lodging$9,79615%
- Food & beverage$6,79910%
- Education$20,00031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 59 | $38,156 |
| Intuitive Surgical | 63 | $26,222 |
| Medtronic | 38 | $5,505 |
| Acell, Inc. | 5 | $3,854 |
| TELA Bio, Inc. | 2 | $203 |
| KCI USA, Inc. | 7 | $194 |
| Convatec Inc. | 3 | $178 |
| Galderma Laboratories, L.p. | 2 | $169 |
| Mallinckrodt Enterprises LLC | 7 | $159 |
| Endologix LLC | 1 | $119 |
| Penumbra, Inc. | 1 | $116 |
| Johnson & Johnson | 4 | $111 |
| Reprise Biomedical, Inc. | 8 | $111 |
| Lexington Medical, Inc. | 3 | $105 |
| Covidien LP | 2 | $105 |
| Baxter Healthcare | 1 | $89 |
| Mallinckrodt Hospital Products Inc. | 2 | $56 |
| AbbVie | 2 | $52 |
| Conmed Corporation | 2 | $51 |
| Stryker | 1 | $47 |
| Organogenesis Inc. | 2 | $43 |
| Novo Nordisk | 2 | $40 |
| Krystal Biotech Inc | 2 | $36 |
| Innocoll Pharmaceuticals Limited | 1 | $24 |
| Enterra Medical, Inc. | 1 | $23 |
| Heron Therapeutics, Inc. | 2 | $22 |
| Aroa Biosurgery Incorporated | 1 | $20 |
| Solventum Corporation | 1 | $18 |
| Olympus America Inc. | 1 | $14 |
| Davol Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Standard Bariatrics, Inc. | 1 | $13 |
| Lucid Diagnostics Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$38,958
- Da Vinci Surgical System$25,273
- PRIMATRIX$16,606
- OMNIGRAFT$4,675
- Signia$3,812
- INTEGRA DERMAL REGENERATION TEMPLATE$2,929
- GENTRIX$2,444
- ADVANCED WOUND CARE$1,916
- INTEGRA WOUND MATRIX (IWM)$1,171
- INTEGRA MESHED BILAYER WOUND MATRIX$1,171
- LigaSure$898
- INTEGRA FLOWABLE WOUND MATRIX$410
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$133
- InnovaMatrix AC$129
- AFX2 Bifurcated Endograft System$119
- Indigo System$116
How this compares
$75,895 in reported general payments places this provider in the 90th percentile of 1,569 surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 14 | $13,160 |
| Omeprazole | 78 | $1,211 |
| Ondansetron OdtOndansetron | 11 | $62 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $40 | $13,16014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,569 surgery providers in Florida.
Other surgery in Fort Myers
- Jorge FlorinWinter Garden$2.2M
- Steven FagienBoca Raton$1.6M
- John MullinaxTampa$1.5M
- Amit TaggarTampa$1.4M
- Panagiotis SarantosGainesville$1.3M
- Keith KimCelebration$1.1M
- Christopher DucoinTampa$1.1M
- Andre TeixeiraOcala$1M
- Richard DiciccoTampa$964K
- Salvatore DocimoTampa$950K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.